Purdue Pharma Bankruptcy Plan Conditionally Approved With $4.3B Sackler Share

Mealey's (September 2, 2021, 1:19 PM EDT) -- WHITE PLAINS, N.Y. — A New York federal bankruptcy judge on Sept. 1 approved an amended reorganization plan for OxyContin maker Purdue Pharma LP that includes $4.3 billion in contributions from the controlling Sackler family and limited liability releases for those members, according to a rough transcript of a hearing filed by a creditor opposing the plan....